ELIBREZE Trademark

Trademark Overview

On Monday, November 22, 2004, a trademark application was filed for ELIBREZE with the United States Patent and Trademark Office. The USPTO has given the ELIBREZE trademark a serial number of 78521271. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 12, 2009. This trademark is owned by Myogen, Inc.. The ELIBREZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders in the cardiovascular, cardiac, vascular and hematology fields
elibreze

General Information

Serial Number78521271
Word MarkELIBREZE
Filing DateMonday, November 22, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 12, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders in the cardiovascular, cardiac, vascular and hematology fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 1, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGILEAD COLORADO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWESTMINSTER, CO 80021
Party NameMyogen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 800215426
Party NameMyogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestminster, CO 800215426

Trademark Events

Event DateEvent Description
Monday, July 27, 2009REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, July 21, 2009PAPER RECEIVED
Monday, January 12, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 12, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 5, 2008EXTENSION 5 GRANTED
Thursday, June 5, 2008EXTENSION 5 FILED
Thursday, June 5, 2008TEAS EXTENSION RECEIVED
Friday, November 16, 2007EXTENSION 4 GRANTED
Friday, November 16, 2007EXTENSION 4 FILED
Friday, November 16, 2007TEAS EXTENSION RECEIVED
Wednesday, June 13, 2007EXTENSION 3 GRANTED
Wednesday, June 13, 2007EXTENSION 3 FILED
Wednesday, June 13, 2007TEAS EXTENSION RECEIVED
Tuesday, March 27, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 2, 2007EXTENSION 2 GRANTED
Thursday, December 7, 2006EXTENSION 2 FILED
Wednesday, December 13, 2006AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 7, 2006TEAS EXTENSION RECEIVED
Thursday, June 15, 2006EXTENSION 1 GRANTED
Thursday, June 1, 2006EXTENSION 1 FILED
Thursday, June 1, 2006TEAS EXTENSION RECEIVED
Tuesday, December 13, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2005NOTICE OF PUBLICATION
Monday, July 11, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 8, 2005ASSIGNED TO LIE
Thursday, July 7, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, June 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 30, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 28, 2005PAPER RECEIVED
Monday, June 27, 2005NON-FINAL ACTION E-MAILED
Monday, June 27, 2005NON-FINAL ACTION WRITTEN
Monday, June 27, 2005ASSIGNED TO EXAMINER
Wednesday, December 1, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

elibreze cardiac vascular hematology fields cardiovascular disorders preparations treatment diseases pharmaceutical